Constipation: Short-Term Use

If you have been constipated for four days, you are uncomfortable, and you want to know whether the box of senna in the pharmacy is going to help — the answer is yes, and this page is about doing it properly. Senna is a licensed over-the-counter laxative in the United States, the United Kingdom, the European Union and most other regulated markets. It has been through placebo-controlled trials. It works in roughly 6 to 12 hours. It costs a few pounds or dollars for a month’s box, and the same molecule is in the cheap generic as in the brand name.

Almost everything that goes wrong with senna is a matter of how long and in what context, not whether. Used for a few days for a genuine bout of constipation, it is one of the more predictable, better-characterised drugs you can buy without a prescription. This article covers the licensed use, the dose, the timing, the forms, the groups who need medical advice first, and the point at which reaching for another tablet is the wrong move.

Table of Contents

1. What Senna Is Licensed to Do
2. How Well It Works: The Trial Evidence
3. Opioid-Induced Constipation
4. Constipation in Older Adults
5. Dose: How Much, and How to Start
6. Timing: Why Bedtime Is the Right Time
7. Forms: Tablets, Tea, Pods, Syrup
8. If It Is Not Working, Do Not Escalate
9. Children and Pregnancy
10. Who Should Not Take Senna
11. Red Flags: When Constipation Needs a Diagnosis
12. What to Do Before and Alongside
13. Key Research Papers
14. Connections

What Senna Is Licensed to Do

Senna leaf and senna pod both hold formal regulatory status as medicines rather than supplements in most markets. In the United States, senna appears in the FDA’s over-the-counter monograph for laxative drug products, which is why a box of Senokot carries a Drug Facts panel and not a Supplement Facts panel. The European Medicines Agency’s Committee on Herbal Medicinal Products has published monographs for both plant parts. The World Health Organization lists senna among essential medicines.

The wording of the indication is narrow and consistent across all of them: short-term treatment of occasional constipation. Not chronic constipation management. Not daily bowel maintenance. Not weight control, cleansing, or bloating. Occasional constipation, short-term.

The corresponding duration statement is equally consistent: use for no more than about one to two weeks without seeking medical advice. Some labels say seven days, some say two weeks; the principle is the same. This is not risk-averse boilerplate — it is a substantive part of the authorisation, based on the electrolyte losses that accumulate with repeated stimulant-laxative use and on the fact that constipation lasting more than a couple of weeks usually has a cause worth finding.

How Well It Works: The Trial Evidence

Two kinds of evidence support senna, and they point the same way.

The placebo-controlled trial

The most useful single study is a Japanese randomised, placebo-controlled trial published in the American Journal of Gastroenterology in 2021 by Morishita and colleagues, which compared senna against magnesium oxide and against placebo in adults with chronic constipation. This is exactly the design that matters: constipation improves substantially on placebo in almost every trial ever run, so a comparison against nothing is uninformative. Senna separated from placebo on stool frequency and symptom scores. Magnesium oxide also worked. The trial did not show senna to be dramatically superior to a well-chosen osmotic agent — it showed that both beat placebo, which is the honest summary.

The pooled analyses

Ford and Suares’s 2011 meta-analysis in Gut pooled randomised trials of laxatives and prescription drugs for chronic idiopathic constipation and found stimulant laxatives among the treatment classes with a demonstrable benefit over placebo. Ramkumar and Rao’s earlier systematic review in the American Journal of Gastroenterology graded the evidence for the traditional laxatives and reached a similar conclusion for senna. Neither review is glowing — both note that many of the underlying trials are old, small, and would not pass modern reporting standards. But the direction of effect is not in dispute.

Put plainly: senna is not the most rigorously trialled laxative on the market (that is probably polyethylene glycol), but it is well past the threshold of “does something.”

Opioid-Induced Constipation

Opioid painkillers — morphine, oxycodone, codeine, tramadol, fentanyl — bind receptors in the gut wall and slow intestinal movement to a crawl. Constipation follows in the majority of people who take them, does not fade with time the way nausea does, and is one of the commonest reasons patients stop taking pain relief they actually need.

Because opioids paralyse motility, a drug that directly stimulates motility is a mechanistically sensible answer. Senna is standard practice here: in hospice and oncology, a laxative is typically started at the same time as the opioid rather than waiting for constipation to appear.

What the trials show:

• Agra and colleagues (1998) randomised terminal cancer patients on opioids to senna or lactulose and found senna at least as effective, at appreciably lower cost.
• Marciniak and colleagues (2014) ran a double-blind active-comparator trial of lubiprostone versus senna in post-operative orthopaedic patients on opioids — a useful modern comparison against a prescription drug.
• The Cochrane review by Candy and colleagues (2015) assessed laxatives in palliative care and reached a deliberately unexciting conclusion: the trials are few and small, and no laxative was clearly superior to another. That is a genuinely negative finding for anyone claiming senna is proven best in this setting. It is not a finding that senna does not work — it is a finding that the evidence cannot rank the options.

Practical note: a stool softener such as docusate is often combined with senna in opioid constipation. The softener adds little on its own in trials, but the combination is widely used and can make the resulting bowel movement less uncomfortable.

Constipation in Older Adults

Constipation is far more common with age — reduced mobility, lower fluid and fibre intake, and a long medication list all contribute. Senna has a reasonable evidence base in this group specifically.

Passmore and colleagues, writing in the BMJ in 1993, randomised long-stay elderly patients to lactulose or a senna-plus-fibre combination and found the senna combination produced more bowel movements. Kinnunen and colleagues reported a similar comparison in Pharmacology the same year. These are old trials in institutional settings, and neither is large — but they are on-point, and they are the reason senna-fibre products remain common in nursing homes.

Two cautions matter more in older adults than in anyone else. First, polypharmacy: diuretics, digoxin, corticosteroids and some antidepressants are all more common with age, and all interact with senna’s potassium losses. Second, faecal impaction — a hard plug of stool that a stimulant laxative pushes against rather than through. Impaction can present as overflow diarrhoea, which is easily mistaken for the laxative working too well. Anyone with a long history of constipation who suddenly starts leaking loose stool needs an examination, not a larger dose.

Dose: How Much, and How to Start

Every serious senna product states its strength in milligrams of sennosides, usually calculated as sennoside B. That number is the dose. Tablet weight, extract ratio and “mg of leaf” are all much less informative.

Start low and go up slowly. The dose–response curve for senna is unhelpfully steep at the top: a dose that is slightly too high does not produce a slightly better bowel movement, it produces griping cramps and watery diarrhoea. Most people who describe senna as “horrible” took too much on the first night.

Drink normally while taking it. Senna moves fluid into the colon, so a person who is already dehydrated has both less margin and a worse result.

Timing: Why Bedtime Is the Right Time

Senna is a prodrug. The sennosides you swallow pass through the stomach and small intestine essentially unchanged and are only converted to the active compound, rhein anthrone, when colonic bacteria strip off their sugar groups. That journey and that conversion take time, which is why the onset is reliably 6 to 12 hours — not 30 minutes.

The practical consequence is simple: take it at bedtime and expect a result in the morning. Taking senna at 9 a.m. because you want relief now is the single most common scheduling error; you will not get relief now, you will get it at 6 p.m., possibly on a train.

If you need something faster and are certain the problem is stool sitting in the rectum rather than higher up, a glycerin suppository works in minutes and is a different tool for a different job. The full mechanism, including why the delay is unavoidable, is covered in How Sennosides Work.

Forms: Tablets, Tea, Pods, Syrup

• Standardised tablets. The most predictable form, and what nearly every trial used. The label tells you the sennoside content. This is the default recommendation.
• Senna tea and tea bags. Popular, cheap, and the hardest form to dose. The amount of sennoside extracted depends on how much leaf is in the bag, water temperature, and — critically — how long it steeps. A bag left in a mug for fifteen minutes while you forget about it can deliver several times the dose of the same bag steeped for three. Unpredictable cramping and diarrhoea from senna tea is a routine story. If you use tea, time the steep.
• Senna pods. Traditionally regarded as gentler than the leaf and preferred in several European preparations. Modern standardised products blur the distinction because both are dosed to sennoside content.
• Syrups and liquids. Common in paediatric and geriatric use, where swallowing tablets is difficult. Measure with the supplied device, not a kitchen spoon.
• Senna with docusate. A very common combination product. The docusate is a stool softener; the senna does the work.
• “Detox” and slimming teas containing senna. A different product category with a different intent, covered in Senna in Weight-Loss and Detox Teas. These frequently do not disclose the sennoside dose at all.

If It Is Not Working, Do Not Escalate

The instinct when a laxative fails is to take more of it. With senna this instinct is wrong often enough to be worth naming, because there are several reasons it might not work, and only one of them is “dose too small.”

1. Not enough time. Six to twelve hours means twelve, sometimes. Judge after a full night, not after four hours.
2. Faecal impaction. If there is a hard, immovable plug, stimulating the colon above it causes pain, not evacuation. This needs an examination and often a suppository or enema first.
3. Low potassium. If you have been using laxatives for a while, low potassium may itself be slowing your colon. More senna deepens the deficiency and worsens the problem. This loop is the single most under-recognised reason for “my laxative stopped working.”
4. Disrupted gut bacteria. Senna needs colonic bacteria to activate it. After a course of broad-spectrum antibiotics the conversion can be reduced.
5. The problem is not slow transit. Pelvic-floor dyssynergia — where the muscles that should relax during defecation contract instead — does not respond to laxatives of any kind. It responds to biofeedback physiotherapy. People with this pattern can take escalating laxatives for years with no benefit.
6. Obstruction. Rare, serious, and the reason for the hard rule below about undiagnosed abdominal pain.

If two nights at a label-appropriate dose produce nothing, stop and get assessed. Do not spend a month climbing the dose.

Children and Pregnancy

Children

Senna is genuinely used in paediatric constipation — but as a prescribed, weight-adjusted therapy, not as a self-selected home remedy. The 2016 Cochrane review by Gordon and colleagues on osmotic and stimulant laxatives in childhood constipation found the overall evidence base weak, with polyethylene glycol the best-supported option. Small trials in specific surgical populations, such as children with repaired anorectal malformations, have compared senna directly with polyethylene glycol.

There is one paediatric-specific harm worth knowing about: senna-containing laxatives have caused blistering and skin breakdown in nappy-wearing children, reported by Spiller and colleagues in 2003. Prolonged skin contact with senna-laden stool in a wet nappy produces a chemical burn-like injury. If a young child on senna develops a severe, blistering nappy rash, that is the likely cause and it needs medical attention.

Do not give senna to a child without a doctor’s or pharmacist’s direction.

Pregnancy and breastfeeding

Constipation in pregnancy is extremely common — progesterone slows the gut and iron supplements make it worse. The standard approach is fibre, fluids and, if needed, a bulk-forming or osmotic laxative first. Senna is used in pregnancy when those are insufficient, on clinical advice, and it is poorly absorbed, which limits systemic exposure. A Hungarian population-based case-control study by Acs and colleagues examined senna use in pregnancy and did not find an association with congenital abnormalities in the offspring; the same group published a companion analysis of constipation treatment more broadly with a similar result. These are observational studies with the usual limitations, not a licence for casual use.

In breastfeeding, only small amounts of active metabolite reach milk and senna is generally considered compatible at normal doses, though loose stools in the infant are occasionally reported. Use the lowest effective dose and mention it to your midwife or doctor.

Who Should Not Take Senna

These are not soft cautions. Each has a specific mechanism behind it.

• Known or suspected bowel obstruction, or ileus. Stimulating peristalsis against a blockage risks perforation. This is the most serious contraindication on the list.
• Undiagnosed abdominal pain, especially with nausea, vomiting or fever. Appendicitis is the classic scenario — a stimulant laxative in an inflamed appendix is dangerous. Belly pain of unknown cause needs a diagnosis before any laxative.
• Inflammatory bowel disease — Crohn’s disease and ulcerative colitis — and other active bowel inflammation. Stimulant laxatives can aggravate an already inflamed bowel.
• Severe dehydration or existing electrolyte disturbance. Senna makes both worse.
• Taking digoxin. Digoxin toxicity rises sharply when potassium falls, and potassium loss is senna’s signature adverse effect. This combination needs medical oversight and potassium monitoring.
• Taking diuretics or corticosteroids. Both lower potassium independently; senna adds to the loss.
• History of laxative misuse or an eating disorder. Not a moral judgement — a pharmacological one. Senna is the most-misused laxative class and re-exposure is a real relapse risk. Discuss with your clinician.
• Significant kidney or heart disease. Less margin for fluid and electrolyte shifts.

Other drug interactions worth raising with a pharmacist: warfarin (diarrhoea can alter vitamin K absorption and INR control), and any oral medication with a narrow therapeutic window, since faster transit can reduce how much is absorbed.

Red Flags: When Constipation Needs a Diagnosis

Constipation is a symptom. Most of the time it is a boring one. Sometimes it is the first sign of something that a laxative will delay the diagnosis of. See a doctor rather than reaching for senna if constipation comes with any of these:

• Blood in the stool, or black tarry stool.
• Unintentional weight loss.
• A persistent change in bowel habit in anyone over 50, or new symptoms with a family history of bowel cancer.
• Iron-deficiency anaemia.
• Severe or worsening abdominal pain, or abdominal swelling with vomiting.
• Complete inability to pass stool or wind — a possible obstruction, and a reason to be assessed urgently rather than to take a laxative.
• Constipation that started with a new medication — the fix may be adjusting that drug.
• Constipation alongside new fatigue, cold intolerance and weight gain, which can point to an underactive thyroid.

What to Do Before and Alongside

Senna is a rescue, not a routine. The measures that keep bowels moving without a drug are unglamorous and genuinely effective:

• Fibre, increased gradually, with fluid. Adding fibre quickly without extra water can make constipation and bloating worse. Build up over two to three weeks.
• Fluid. Hard stool is dry stool. Mild dehydration is a common and trivially fixable cause.
• Movement. Even walking helps colonic motility; immobility is a major driver of constipation in hospital and care settings.
• Use the gastrocolic reflex. The colon is most active in the 30 minutes after a meal, especially breakfast. Give yourself unhurried, unpressured toilet time then, and never ignore the urge — repeatedly deferring it blunts the signal.
• Position. A footstool that raises the knees above the hips straightens the anorectal angle and makes defecation mechanically easier.
• Prunes. The food with the best trial evidence for constipation, thanks to fibre plus sorbitol. Kiwifruit has supportive data too.
• Review your medications. Opioids, iron, some antidepressants, calcium-channel blockers and anticholinergics are all common culprits.

Our Natural Constipation Relief page covers these in detail, and Prunes looks at the trial data on the fruit specifically.

Key Research Papers

Each identifier below was verified against NCBI E-utilities — author, title, journal and year had to match before it was written.

Efficacy and comparative trials

1. Morishita D, Tomita T, Mori S, et al. Senna versus magnesium oxide for the treatment of chronic constipation: a randomized, placebo-controlled trial. The American Journal of Gastroenterology. 2021;116(1):152–161. Human trial; senna separated from placebo, and magnesium oxide also worked.
2. Ford AC, Suares NC. Effect of laxatives and pharmacological therapies in chronic idiopathic constipation: systematic review and meta-analysis. Gut. 2011;60(2):209–218. Pooled human trials.
3. Ramkumar D, Rao SSC. Efficacy and safety of traditional medical therapies for chronic constipation: systematic review. The American Journal of Gastroenterology. 2005;100(4):936–971.
4. Passmore AP, Wilson-Davies K, Stoker C, Scott ME. Chronic constipation in long stay elderly patients: a comparison of lactulose and a senna-fibre combination. BMJ. 1993;307(6907):769–771. Human trial in institutionalised older adults.
5. Kinnunen O, Winblad I, Koistinen P, Salokannel J. Safety and efficacy of a bulk laxative containing senna versus lactulose in the treatment of chronic constipation in geriatric patients. Pharmacology. 1993;47(Suppl 1):253–255.

Opioid-induced constipation

1. Agra Y, Sacristán A, González M, Ferrari M, Portugués A, Calvo MJ. Efficacy of senna versus lactulose in terminal cancer patients treated with opioids. Journal of Pain and Symptom Management. 1998;15(1):1–7. Human randomised trial.
2. Candy B, Jones L, Larkin PJ, Vickerstaff V, Tookman A, Stone P. Laxatives for the management of constipation in people receiving palliative care. Cochrane Database of Systematic Reviews. 2015;(5):CD003448. Negative for superiority — too few, too small trials to rank laxatives against one another.
3. Marciniak CM, Toledo S, Lee J, et al. Lubiprostone vs senna in postoperative orthopedic surgery patients with opioid-induced constipation: a double-blind, active-comparator trial. World Journal of Gastroenterology. 2014;20(43):16323–16333. Human trial.

Children, pregnancy and safety in special groups

1. Gordon M, MacDonald JK, Parker CE, Akobeng AK, Thomas AG. Osmotic and stimulant laxatives for the management of childhood constipation. Cochrane Database of Systematic Reviews. 2016;(8):CD009118. Found the paediatric evidence base weak overall.
2. Santos-Jasso KA, Arredondo-García JL, Maza-Vallejos J, Lezama-Del Valle P. Effectiveness of senna vs polyethylene glycol as laxative therapy in children with constipation related to anorectal malformation. Journal of Pediatric Surgery. 2017;52(1):84–88. Human trial in a specific surgical population.
3. Spiller HA, Winter ML, Weber JA, Krenzelok EP, Anderson DL, Ryan ML. Skin breakdown and blisters from senna-containing laxatives in young children. The Annals of Pharmacotherapy. 2003;37(5):636–639. Case series — the paediatric harm most parents have never heard of.
4. Acs N, Bánhidy F, Puhó EH, Czeizel AE. Senna treatment in pregnant women and congenital abnormalities in their offspring: a population-based case-control study. Reproductive Toxicology. 2009;28(1):100–104. Observational; no association found.
5. Acs N, Bánhidy F, Puhó EH, Czeizel AE. No association between severe constipation with related drug treatment in pregnant women and congenital abnormalities in their offspring. Congenital Anomalies (Kyoto). 2010;50(1):15–20.

Context: constipation management overall

1. Bharucha AE, Lacy BE. Mechanisms, evaluation, and management of chronic constipation. Gastroenterology. 2020;158(5):1232–1249. Where senna sits in a stepwise approach.
2. Wald A. Constipation: advances in diagnosis and treatment. JAMA. 2016;315(2):185–191.
3. Cirillo C, Capasso R. Constipation and botanical medicines: an overview. Phytotherapy Research. 2015;29(10):1488–1493.

Live PubMed Searches

1. Senna and constipation, randomised trials
2. Sennosides dose–response
3. Opioid-induced constipation, first-line laxatives
4. Senna in older adults
5. Faecal impaction and overflow diarrhoea
6. Dyssynergic defecation and biofeedback
7. Senna in bowel preparation
8. Constipation alarm features

Connections

• All Herbs
• Senna Benefits — hub
• How Sennosides Work — why the delay, why the cramps
• Dependence, Melanosis Coli and Long-Term Risk
• Senna in Weight-Loss and Detox Teas
• Senna — main topic page
• Cassia alata (Ringworm Bush) — a different Senna species, used topically
• Constipation — causes and red flags
• Natural Constipation Relief
• Prunes
• Marshmallow Root
• Slippery Elm
• Potassium
• Gastroenterology

Back to Table of Contents